CHEBI:132302 - (8S,9R)-EET

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name (8S,9R)-EET
ChEBI ID CHEBI:132302
ChEBI ASCII Name (8S,9R)-EET
Definition An 8,9-EET in which the epoxy moiety has 8S,9R-configuration.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C20H32O3
Net Charge 0
Average Mass 320.467
Monoisotopic Mass 320.23514
InChI InChI=1S/C20H32O3/c1-2-3-4-5-6-7-8-9-12-15-18-19(23-18)16-13-10-11-14-17-20(21)22/h6-7,9-10,12-13,18-19H,2-5,8,11,14-17H2,1H3,(H,21,22)/b7-6-,12-9-,13-10-/t18-,19+/m1/s1
InChIKey DBWQSCSXHFNTMO-ZZMPYBMWSA-N
SMILES C(CCC)C/C=C\C/C=C\C[C@@H]1[C@H](C/C=C\CCCC(O)=O)O1
Metabolite of Species Details
Rattus norvegicus (NCBI:txid10116) See: PubMed
Roles Classification
Chemical Role(s): Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): rat metabolite
Any mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via 8,9-EET )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via EET )
Application(s): vasoconstrictor agent
Drug used to cause constriction of the blood vessels.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
(via EET )
anti-inflammatory drug
A substance that reduces or suppresses inflammation.
(via EET )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing (8S,9R)-EET (CHEBI:132302) has role rat metabolite (CHEBI:86264)
(8S,9R)-EET (CHEBI:132302) has role vasoconstrictor agent (CHEBI:50514)
(8S,9R)-EET (CHEBI:132302) is a 8,9-EET (CHEBI:34490)
(8S,9R)-EET (CHEBI:132302) is conjugate acid of (8S,9R)-EET(1−) (CHEBI:131974)
(8S,9R)-EET (CHEBI:132302) is enantiomer of (8R,9S)-EET (CHEBI:132303)
Incoming (8S,9R)-EET(1−) (CHEBI:131974) is conjugate base of (8S,9R)-EET (CHEBI:132302)
(8R,9S)-EET (CHEBI:132303) is enantiomer of (8S,9R)-EET (CHEBI:132302)
IUPAC Name
(5Z)-7-{(2S,3R)-3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid
Synonyms Sources
(8S,9R)-EpETrE ChEBI
(8S,9R)-epoxy-(5Z,11Z,14Z)-eicosatrienoic acid ChEBI
(8S,9R)-epoxy-(5Z,11Z,14Z)-icosatrienoic acid ChEBI
8(S),9(R)-EET ChEBI
8S,9R-EET LIPID MAPS
8S,9R-EpETrE LIPID MAPS
8S,9R-epoxy-5Z,11Z,14Z-eicosatrienoic acid LIPID MAPS
Manual Xref Database
LMFA03080019 LIPID MAPS
View more database links
Registry Number Type Source
4697202 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
1928373 PubMed citation Europe PMC
20158473 PubMed citation Europe PMC
20972997 PubMed citation Europe PMC
7738183 PubMed citation Europe PMC
7840649 PubMed citation Europe PMC
8447831 PubMed citation Europe PMC
Last Modified
28 June 2016